학술논문
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial
Document Type
Article
Author
Gullo, G.; J. Eustace, A.; Canonici, A.; M. Collins, D.; O’Donovan, N.; Kennedy, M.J.; Grogan, L.; Breathhnach, O.; McCaffrey, J.; Keane, M.; Leonard, G.; Donnellan, P.; Martin, M.J.; Gupta, R.; O’Connor, M.; Calvert, P.M.; Walshe, J.; McDermott, E.; Tryfonopoulos, D.; Crown, J.; Scott, K.; Hernando, A.; Parker, I.; Murphy, V.; W. Murray, D.; C. O’Farrell, A.; T. Byrne, A.; Maratha, A.; Rafferty, M.; M. Gallagher, W.; Dicker, P.; Ky, B.; Moulton, B.
Source
In: Therapeutic Advances in Medical Oncology . (Therapeutic Advances in Medical Oncology, 1 July 2019, 11)
Subject
Language
English
ISSN
17588359
17588340
17588340